Announced Wed, 13 May · 17:10 IST

please refer attachment

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹26.83
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-5.0-1.6-5.3-5.9-2.3-6.8-4.3-4.3
Up moveDown movePending
AI summary

Emmessar Biotech & Nutrition Ltd has published its audited financial results for Q4 FY2026 and the full financial year ended March 31, 2026 in newspapers (Free Press Journal and Nav Shakti), as required under SEBI Listing Regulations. The results were approved by the Board of Directors on May 11, 2026. The filing also includes an extract of S.P. Capital Financing Ltd (Scrip Code: 530289) results showing Q4 total income of Rs. 68.38 Lakhs, Q4 net loss of Rs. 285.70 Lakhs, but full year net profit of Rs. 350.18 Lakhs (standalone) on total income of Rs. 1,163.10 Lakhs. Additionally, Punjab National Bank has published an e-auction notice for commercial property at Filix Tower, Bhandup West, Mumbai owned by Aditya Investment and Exim Trade Co. with outstanding dues of Rs. 13.76 Cr as on March 31, 2026, scheduled for May 30, 2026.

Likely market impact

The filing confirms regulatory compliance for results publication. S.P. Capital Financing Ltd showed strong annual profitability but a significant Q4 loss, indicating potential seasonality or one-time charges. The PNB e-auction indicates stressed asset recovery action.